Abstract
Since camel milk has been attributed with various medicinal properties not found in bovine milk, we are systematically examining the differences between different proteins in bovine and camel milk. The purpose of this study is to investigate the structural differences between the bovine and camel α- lactalbumins. α-Lactalbumin is a highly abundant protein present in the milk of all mammalian species. Here we found several structural differences between bovine and camel α-lactalbumins: camel protein is more stable towards thermal and pHmediated denaturation but less stable towards guanidine hydrochloride-mediated unfolding, aggregates faster and is predicted to be more disordered than bovine α- lactalbumin.
Keywords: α-lactalbumin, CD, fluorescence, guanidine hydrochloride-mediated unfolding, aggregation, intrinsically disordered protein.
Graphical Abstract
Protein & Peptide Letters
Title:α-Lactalbumin: Of Camels and Cows
Volume: 23 Issue: 12
Author(s): Jennifer M. Redington, Leonid Breydo, Hussein A. Almehdar, Elrashdy M. Redwan and Vladimir N. Uversky
Affiliation:
Keywords: α-lactalbumin, CD, fluorescence, guanidine hydrochloride-mediated unfolding, aggregation, intrinsically disordered protein.
Abstract: Since camel milk has been attributed with various medicinal properties not found in bovine milk, we are systematically examining the differences between different proteins in bovine and camel milk. The purpose of this study is to investigate the structural differences between the bovine and camel α- lactalbumins. α-Lactalbumin is a highly abundant protein present in the milk of all mammalian species. Here we found several structural differences between bovine and camel α-lactalbumins: camel protein is more stable towards thermal and pHmediated denaturation but less stable towards guanidine hydrochloride-mediated unfolding, aggregates faster and is predicted to be more disordered than bovine α- lactalbumin.
Export Options
About this article
Cite this article as:
Redington M. Jennifer, Breydo Leonid, Almehdar A. Hussein, Redwan M. Elrashdy and Uversky N. Vladimir, α-Lactalbumin: Of Camels and Cows, Protein & Peptide Letters 2016; 23 (12) . https://dx.doi.org/10.2174/0929866523666160517123738
DOI https://dx.doi.org/10.2174/0929866523666160517123738 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ethanolamine: A Potential Promoiety with Additional Effects on the Brain
CNS & Neurological Disorders - Drug Targets Nerve Conduction Through Dendrites via Proton Hopping
Current Computer-Aided Drug Design Abeta Immunotherapy and Other Means to Remove Amyloid
Current Drug Targets - CNS & Neurological Disorders Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Current Drug Targets Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR
Current Neuropharmacology Efficient In Vitro Refolding and Characterization of a New Peptide from the Scorpion Buthotus saulcyi Venom Produced in Escherichia coli
Protein & Peptide Letters Metabotropic Glutamate Receptors and Interacting Proteins in Epileptogenesis
Current Neuropharmacology Genetic Analysis of CYP2D6 Polymorphism in Indian Populations and its Pharmacogenetic Implications
Current Pharmacogenomics and Personalized Medicine Epigenetic Drugs for Multiple Sclerosis
Current Neuropharmacology Pharmacologic Treatment with GABAB Receptor Agonist of Methamphetamine-Induced Cognitive Impairment in Mice
Current Neuropharmacology Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Current Medicinal Chemistry Heterocyclic Secretase Inhibitors for the Treatment of Alzheimer’s Disease: An Overview
Central Nervous System Agents in Medicinal Chemistry Conference Report: (Annual Advances in Neurorestoratology: A Summary of IANR VI and 10th GCNN Conference, Bucharest, Romania, April 4-7, 2013)
CNS & Neurological Disorders - Drug Targets Nitric Oxide: Cancer Target or Anticancer Agent?
Current Cancer Drug Targets Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19
Current Pharmaceutical Design Children with Medical Complexity: Forwarding a Policy Agenda
Current Pediatric Reviews Structures Behind the Amyloid Aggregation of α-Synuclein: An NMR based Approach
Current Protein & Peptide Science Sexual Risk Reduction Interventions for HIV Prevention among South AfricanYouth: A Meta-Analytic Review
Current HIV Research Quality Assessment of Clinical Practice Guidelines for the Prescription of Antidepressant Drugs During Pregnancy
Current Clinical Pharmacology A Genetic Dissection of Antipsychotic Induced Movement Disorders
Current Medicinal Chemistry